U.S. market Closed. Opens in 11 hours 47 minutes

ENSC | Ensysce Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue2.23M2.52M3.53M3.93M1.76MN/A
Cost of Revenue7.59M19.84M151.001.37M3.33M1.56M
Gross Profit-5.36M-17.31M3.53M2.56M-1.56M-1.56M
Operating Expenses12.95M24.22M19.87M1.61M3.33M-600.00K
Selling, General & Admin5.36M6.91M18.71M1.15M3.33MN/A
Research & Development7.59M19.84M4.69M4.39M3.40MN/A
Other Operating ExpensesN/A-2.52M-3.53M-3.93MN/AN/A
Operating Income-10.72M-24.22M-19.87M-1.61M-3.33M-959.24K
Other Expenses / Income91.92K14.41K-9.28M1.45M4.25M3.64M
Before Tax Income-10.63M-24.21M-29.15M-160.88K921.15K2.68M
Income Tax Expenses-264.00753.88K-151.00777.85K-555.20K-553.92K
Net Income-10.61M-24.96M-29.15M-938.73K1.48M2.12M
Interest Expenses-353.94K109.53K1.30M995.50KN/AN/A
Basic Shares Outstanding2.26M179.93K84.02K65.70K98.26K6.00M
Diluted Shares Outstanding2.26M179.93K84.02K68.78K98.26K6.00M
EBITDA-10.72M-24.22M-19.87M-1.61M-3.33M-959.24K
EBITDA Margin-480.52%-959.91%-562.71%-41.03%-188.70%0.00%
EBIT-10.97M-24.10M-27.85M834.62K921.15K1.57M
EBIT Margin-491.69%-954.99%-788.70%21.23%52.22%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙